This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.G Polanczyk , LA Rohde . Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 2007; 20: 386–392.
3.SV Faraone , T Spencer , M Aleardi , et al. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2004; 24: 24–29.
5.WO Cooper , LA Habel , CM Sox , et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011; 365: 1896–1904.
6.LA Habel , WO Cooper , CM Sox , et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011; 306: 2673–2683.
7.LK Leslie , ME Alexander , TA Trikalinos , et al. Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder. Circ Cardiovasc Qual Outcomes 2008; 1: 134–137.
8.R Buchhorn , A Conzelmann , C Willaschek , et al. Heart rate variability and methylphenidate in children with ADHD. Atten Defic Hyperact Disord 2012; 4: 85–91.
9.MT La Rovere , JT Bigger Jr, FI Marcus , et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 1998; 351: 478–484.
10.M Vaseghi , K Shivkumar . The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis 2008; 50: 404–419.
11.R Buchhorn , C Muller , C Willaschek , et al. How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD. ISRN Pharmacol 2012; 2012: 170935.
12.A Roggen , M Pavlovic , JP Pfammatter . Frequency of spontaneous ventricular tachycardia in a pediatric population. Am J Cardiol 2008; 101: 852–854.
13.S Wang , W Zhu , RM Hamilton , et al. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm 2010; 7: 1725–1731.
16.S Kinoshita , S Ogawa , T Mitsuoka . Reverse effects of exercise on the sinus and parasystolic cycle lengths. J Electrocardiol 1996; 29: 131–137.
17.S Kinoshita , T Mitsuoka . Effect of standing on ventricular parasystole: shortening of the parasystolic cycle length. Heart 1997; 77: 133–137.
18.GA Lanza , M Lucente , AG Rebuzzi , et al. Ventricular parasystole: a chronobiologic study. Pacing Clin Electrophysiol 1986; 9: 860–867.
19.S Prasad , AJ Furr , S Zhang , et al. Baseline values from the electrocardiograms of children and adolescents with ADHD. Child Adolesc Psychiatry Ment Health 2007; 1: 11.
20.G Fazio , G Novo , L Sutera , et al. Sympathetic tone and ventricular tachycardia. J Cardiovasc Med (Hagerstown) 2008; 9: 963–966.
21.MR Rosen , BF Hoffman . The vagus and the ventricles. Circ Res 1978; 42: 1.
22.TE Wilens , JB Prince , TJ Spencer , et al. Stimulants and sudden death: what is a physician to do? Pediatrics 2006; 118: 1215–1219.
23.AS Batra , ME Alexander , MJ Silka . Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason. Pediatr Cardiol 2012; 33: 394–401.